Ativo
BioNTech
Pioneer of mRNA-based immunotherapies
Fabricantes
- País
- Germany
- Fundado
- 2008
- Cidade sede
- —
- Endereço sede
- An der Goldgrube 12, 55131 Mainz, Germany
- info@biontech.de
- Telefone
- +49 6131 90840
Sobre
Founded in 2008 by Uğur Şahin and Özlem Türeci, BioNTech specializes in mRNA-based vaccines and cancer immunotherapies. Co-developed the first approved mRNA COVID-19 vaccine with Pfizer.
Vacinas
Nenhum dado disponível
FAQ
Nenhum item FAQ disponível.